Arbutus Biopharma Corp (ABUS) — Cash Flow Quality Index
Arbutus Biopharma Corp (ABUS) has a Cash Flow Quality Index of -6.24x as of June 2025. Operating cash flow of $-15.75 Million is below net income of $2.52 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Arbutus Biopharma Corp (ABUS) investment intensity to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Arbutus Biopharma Corp Cash Flow Quality Index (2006–2012)
Historical Cash Flow Quality Index for Arbutus Biopharma Corp across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Arbutus Biopharma Corp tangible equity quality to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Arbutus Biopharma Corp (2006–2012)
Year-by-year earnings quality comparison for Arbutus Biopharma Corp. For live market cap and the full company financial profile, see ABUS market cap.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2012 | 1.11x | $33.27 Million | $29.95 Million | ▲ +865.7% |
| 2006 | -0.15x | $-2.62 Million | $18.08 Million | — |